Biomet Hip Replacement Lawsuits: Bernstein Liebhard LLP Notes New Explant Preservation Order in Biomet M2a Magnum Hip Replacement Litigation

Share Article

The Firm continues to investigate Biomet hip implant lawsuits on behalf of individuals who suffered hip implant failure, metallosis and other complications allegedly due to the metal-on-metal Biomet M2a Magnum hip implant.

Bernstein Liebhard LLP | Consumer Injury Lawyers
This Order will ensure that the integrity of any evidence collected during Biomet hip implant revision surgeries is preserved. Such evidence can be vital to proving plaintiffs’ claims.

A new Explant Preservation Order has been issued which applies to the scores of Biomet hip replacement lawsuits currently pending in a multidistrict litigation in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. The Order, dated March 7, 2013, establishes a protocol designed to enable preservation and analysis of explanted Biomet M2a hip implants and surrounding tissue. Among other things, the Order stipulates that neither party involved in Biomet hip lawsuits will conduct destructive testing on an explanted M2a Magnum hip device without prior written consent of the other party or by order of the Court. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)

“This Order will ensure that the integrity of any evidence collected during Biomet hip implant revision surgeries is preserved. Such evidence can be vital to proving plaintiffs’ claims,” says Bernstein Liebhard LLP, a nationwide law firm representing clients in Biomet hip implant lawsuits. The Firm continues to offer free and confidential legal reviews to individuals allegedly injured by the metal-on-metal hip implant Magnum M2a hip.

Biomet Hip Implant Lawsuits
According to court documents, at least 141 Biomet hip lawsuits have been filed in the litigation underway in the Northern District of Indiana. All of the claims allege the Biomet M2a Magnum hip replacement can generate high levels of metal ions, leading to metallosis in the surrounding tissue and early failure of the device.

In January, the U.S. Food & Drug Administration (FDA) issued new guidance for patients with metal-on-metal hip implants like the Biomet M2a Magnum, advising doctors to consider metal ion testing if patients are experiencing symptoms of hip implant failure. The FDA also said it had proposed a new rule that would make metal-on-metal hip implants ineligible for the agency’s 510(k) clearance process, which allowed such devices to come to market without human testing.*

Biomet is just one of several manufacturers facing lawsuits over metal-on-metal hip implants. The lawyers at Bernstein Liebhard LLP are actively filing lawsuits in the multidistrict litigation established in the U.S. District Court, Northern District of Ohio, for actions involving the DePuy ASR hip implant (MDL No. 2197). The Firm is also involved in the federal litigation underway in the Northern District of Texas concerning the metal-on-metal DePuy Pinnacle hip device (MDL No. 2244), where partner Jeffrey S. Grand is serving on the Plaintiffs’ Steering Committee.
Free case evaluations are also being offered to patients impacted by the July 2012 Stryker Rejuvenate recall, and the June 2012 Smith & Nephew metal liner recall. In addition, Bernstein Liebhard LLP continues to investigate cases concerning the Wright Profemur and Conserve metal hip implants.

Victims of metallosis, hip implant failure, and other serious complications allegedly caused by metal-on-metal hip replacements may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. For more information on filing a Biomet hip replacement lawsuit, as well as additional information regarding complications associated with metal-on-metal hip implants, please visit Bernstein Liebhard’s website. For additional information, please contact one of our attorneys today by calling 1-877-779-1414.


About Bernstein Liebhard
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website